US$ 25.14
pharma news today obesity drugs glp-1 Giants Bet on Next-Generation Treatments to Sustain Growth GLP-1 Drug Market: the rapid
Description
Q: Is that for people on GLP-1s specifically

Fr du forpligter dig, kan du teste svartider via chat eller mail og se, om hjlpen er bde hurtig og prcis

[DOI] [PubMed] [Google Scholar] 24

doi: 10.1016/j.ejphar.2004.09.008 107 McKayDLBlumbergJB

In a study comparing tirzepatide and semaglutide, at 12 months, treatment with tirzepatide lead to 6.9% higher weight loss as compared to treatment with semaglutide 14
Orforglipron's 8% average sits below both of those benchmarks
